Related Experiment Videos
[Pemphigoid gestationis: treatment by topical class I corticosteroid]
L Valeyrie1, B Lebrun-Vignes, N Bodak
1Service de Dermatologie, Hôpital Bichat Claude Bernard, Paris.
Annales De Dermatologie Et De Venereologie
|June 28, 2001
Summary
Severe pemphigoid gestationis, a pregnancy rash, can be effectively treated with potent topical corticosteroids, offering a safer alternative to systemic steroids for both mother and child.
Area of Science:
- Dermatology
- Obstetrics
- Immunodermatology
Background:
- Pemphigoid gestationis (PG) is a rare pregnancy-specific autoimmune blistering disease.
- Severe PG cases are typically managed with systemic corticosteroids, carrying potential maternal and pediatric side effects.
Observation:
- A case of generalized pemphigoid gestationis in a 37-year-old woman is presented.
- Diagnosis was confirmed by direct immunofluorescence and detection of Herpes Gestationis Factor.
- Initial treatment with potent topical betamethasone dipropionate was ineffective.
Findings:
- The patient achieved successful disease remission with clobetasol propionate 0.05% cream, a very potent topical corticosteroid.
- The infant was born in good health without premature delivery.
Implications:
- This case suggests that very potent topical corticosteroids can be an effective and well-tolerated treatment for severe pemphigoid gestationis.
- Highlights a potentially safer therapeutic option compared to systemic corticosteroids, minimizing risks for mother and child.